TE

Tenpoint Therapeutics

3 known investors

tenpointtherapeutics.com ↗

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.

Investors · 3

AD

AdBio partnersParis

F-

F-Prime Capital PartnersCambridge · $3M – $10M

SO

Sofinnova PartnersParis · $540K – $27M